News
Crown Laboratories and Revance Announce Entry Into Merger Agreement
Crown Laboratories, Inc., a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc., a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, today announced that they have...
Drug Research
Tonix advances development of TNX-801 to prevent mpox infection
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, has reiterated its commitment to advance development of its live attenuated virus vaccine, TNX-801 , for preventing mpox and other infectious diseases....
News
LSPedia & Pharma Logistics Partner to revolutionize pharmaceutical reverse logistics and supply chain visibility
LSPedia, a SaaS solution leader in global product traceability, announces a strategic partnership with Pharma Logistics, the industry leader in pharmaceutical reverse distribution. This collaboration aims to transform the pharmaceutical supply chain by offering turnkey compliance, unprecedented data visibility,...
Drug Research
Nuntius Therapeutics Announces Collaboration with Taiho Pharmaceutical to Develop Next-Generation mRNA Therapies
Nuntius Therapeutics, a biotech company developing transformative mRNA therapies through their advanced delivery technology announced that they have entered into a collaboration agreement with Taiho Pharmaceutical Co., Ltd. (“Taiho”), a leading company in Japan for developing innovative medicines for...
News
AstraZeneca Monotherapy for Gastric Cancer Gains Third Approval in China
AstraZeneca and Daiichi Sankyo’s Enhertu has received conditional approval in China as a monotherapy for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received two or more prior...
Drug Research
Nanoform and Takeda to Collaborate on Plasma-Derived Therapy Formulation
Nanoform Finland Plc , the medicine performance-enhancing company announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business Unit of Takeda Pharmaceuticals, Inc., the R&D-driven biopharmaceutical company headquartered in Japan, to develop innovative...
Drug Research
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
Baxter International Inc., a global medtech leader, and funds managed by global investment firm Carlyle announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter's Kidney Care segment, to be named Vantive, for $3.8...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.